DISPLAY OF MRNAS FROM NORMAL TUMORIGENIC CELLS

Information

  • Research Project
  • 2104307
  • ApplicationId
    2104307
  • Core Project Number
    R43CA062832
  • Full Project Number
    1R43CA062832-01
  • Serial Number
    62832
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/1994 - 30 years ago
  • Project End Date
    2/28/1995 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    9/15/1994 - 30 years ago
  • Budget End Date
    2/28/1995 - 29 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/14/1994 - 30 years ago
Organizations

DISPLAY OF MRNAS FROM NORMAL TUMORIGENIC CELLS

Differential gene expression is a highly regulated process which controls normal cell growth and differentiation; its abnormality is the underlying cause of disease states such as cancer. Gen-Hunter corporation's objective is twofold: (1) To provide the biomedical research community with complete line of reagent systems based on the latest technological breakthrough known as Differential Display. (2) To use our expertise to search for early diagnostic markers or therapeutic targets for disease states such as cancer. The reagent systems from GenHunter have made identifications and clonings of differentially expressed genes within easy reach for every researcher. The principle of Differential Display is to systematically distribute mRNA 3' termini on a denaturing polyacrylamide gel after RNA-PCR using multiple combinations of anchored oligo-dT and arbitrary decamers. This proposed Selective Display approach modifies the method by using, instead of anchored oligo-dT primers, a set of gene family-specific decamers in combinations with arbitrary decamers to display only those genes of interest. Thus it complements Differential Display by narrowing down the scope of a gene search while allowing only the coding regions of mRNAs to be displayed. If successful, this work will lead to more lines of commercial reagent systems for the general research community and will greatly speed up hunting down many important disease-causing genes.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    394
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    GENHUNTER CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    NASHVILLE
  • Organization State
    TN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    372113671
  • Organization District
    UNITED STATES